Physician profile
Mark A Curzan
NPI 1902870116
$800.67
in general payments reported to CMS, 2019-2025
10 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.01 · 2020: $36.47 · 2023: $344 · 2024: $43.23 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $334.77 | 2019-2025 | Healicoil, Lens 4k, Acufex Trunav |
| Tricoast Surgical Solutions LLC | $297.25 | 2023-2025 | |
| Boston Scientific Corporation | $25.36 | 2024 | Artisan |
| Abbott Laboratories | $25.13 | 2023 | Penta |
| Bioventus LLC | $23.43 | 2023 | Durolane |
| Collegium Pharmaceutical, INC. | $22.89 | 2023 | Belbuca |
| Vericel Corporation | $19.67 | 2020 | |
| Siemens Medical Solutions USA, INC. | $18.35 | 2025 | Magnetom Free.Max, Magnetom Altea |
| Stryker Corporation | $17.02 | 2025 | Allograft |
| Endo Pharmaceuticals INC. | $16.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Curzan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.